Scarica l'app Stockscreener
990.33
0.72%
7.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP‑1 Market? - The Motley Fool
Mounjaro weight loss trend: What Lilly’s hot drug really means for you - AD HOC NEWS
WHO Foundation announces collaboration with Lilly to strengthen health systems for obesity care | Corporate - EQS News
Chief technology officer spent whole career at Lilly - Indianapolis Business Journal
Morgan Stanley reiterates Overweight on Eli Lilly stock, $1,313 target By Investing.com - Investing.com India
Eli Lilly (LLY) Partners with GoodRx for Expanded Access to Zepb - GuruFocus
Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade) (NYSE:LLY) - Seeking Alpha
Talking Business with Don Cunningham: With Eli Lilly in the Valley, a life sciences flower blooms - The Morning Call
UBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,250 - 富途牛牛
Integrity Advisory Solutions LLC Makes New $1.07 Million Investment in Eli Lilly and Company $LLY - MarketBeat
Lilly plucks Flagship, bluebird vet for regenerative medicine unit; Novo's new China president - Endpoints News
Pitcairn Co. Sells 1,346 Shares of Eli Lilly and Company $LLY - MarketBeat
Roche's Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli LillyRoche Holding (OTC:RHHBY) - Benzinga
‘Project Kennedy’: An inside look at the effort to bring Eli Lilly to Pa.’s Lehigh Valley | Opinion - lehighvalleylive
Upper Macungie approves tax breaks for Eli Lilly’s proposed manufacturing campus - WFMZ.com
Lilly targets employers in new bid to broaden access to obesity drugs - HR Dive
Eli Lilly and Company (NYSE:LLY) Trading Down 2.1%Here's Why - MarketBeat
Eli Lilly Just Launched a New Program to Make GLP‑1 Weight‑Loss Drugs Cheaper for Millions of Workers - inc.com
Teladoc Health joins Eli Lilly Employer Connect platform to expand workplace health options - Traders Union
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? - AOL.com
Morgan Stanley reiterates Eli Lilly stock rating on new obesity platform - Investing.com
Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear? - Yahoo Finance UK
Eli Lilly (LLY) Launches Employer Connect for Obesity Drug Acces - GuruFocus
Eli Lilly and Company $LLY Shares Sold by Orion Porfolio Solutions LLC - MarketBeat
Eli Lilly Targets Employer Coverage Gap With New Obesity Drug Access Platform - Benzinga
This Under-the-Radar Stock Could Be the Next Big SplitAnd Early Investors Could Win Big - AOL.com
Lilly launches employer platform for obesity drug access - Investing.com
Eli Lilly and Co's first large-scale AI factory worldwide has been put into operation, equipped with over 1,000 GPUs. - 富途牛牛
Lilly launches employer-connect platform to broaden weight-loss drug access - Reuters
Eli Lilly launches program for employers to subsidize cost of obesity drug outside insurance - statnews.com
Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S. - CNBC
Quantbot Technologies LP Cuts Stake in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Acquired by Davidson Capital Management Inc. - MarketBeat
Crossmark Global Holdings Inc. Sells 1,008 Shares of Eli Lilly and Company $LLY - MarketBeat
Corient IA LLC Acquires 1,000 Shares of Eli Lilly and Company $LLY - MarketBeat
Cambria Investment Management L.P. Purchases 1,026 Shares of Eli Lilly and Company $LLY - MarketBeat
Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients - Eli Lilly and Company
Eli Lilly confirms oral GLP-1 weight-loss drug being evaluated by TGA - AFR
Eli Lilly’s Nvidia AI Deal And Pipeline Progress Versus Rich Valuation - simplywall.st
Eli Lilly and Company completed the acquisition of Ventyx Biosciences, Inc. from New Science Ventures, LLC, Affinity Asset Advisors, LLC, The Vanguard Group, Inc., and others. - marketscreener.com
Eli Lilly and booming weight-loss pharma industry now 20% of Irish goods exports - Irish Examiner
Ventyx Biosciences completes $1.2 billion acquisition by Eli Lilly, delists from Nasdaq - Investing.com India
Eli Lilly Unusual Options Activity For March 04 - Benzinga
Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval - Reuters
Eli Lilly & Co (NYSE:LLY): A High-Growth Dividend Stock for Discerning Investors - ChartMill
Richard C. Young & CO. LTD. Makes New $13.88 Million Investment in Eli Lilly and Company $LLY - MarketBeat
Picton Mahoney Asset Management Lowers Holdings in Eli Lilly and Company $LLY - MarketBeat
GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - GlobeNewswire Inc.
2 Top Growth Stocks to Buy in the First Half of 2026 - AOL.com
Does Lilly’s Broad Pipeline Wins in Obesity and Immunology Reshape the Bull Case for LLY? - simplywall.st
Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,300 - 富途牛牛
Eli Lilly and Company (NYSE:LLY) Shares Down 1%Should You Sell? - MarketBeat
Ventyx Biosciences shareholders approve merger with Eli Lilly - Investing.com
Eli Lilly (LLY) Monitored as FDA Targets Telehealth Firms for Mi - GuruFocus
Eli Lilly & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Eli Lilly and Company $LLY Shares Bought by Victory Capital Management Inc. - MarketBeat
Lilly in the Valley: An Inside Look at Eli Lilly’s Lehigh Valley Investment - Fairfield Sun Times
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Eli Lilly and Company $LLY Stock Position Lowered by State Farm Mutual Automobile Insurance Co. - MarketBeat
William Blair Investment Management LLC Lowers Holdings in Eli Lilly and Company $LLY - MarketBeat
South Dakota Investment Council Has $43.08 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
CI Investments Inc. Has $256.59 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - Eli Lilly and Company
Eli Lilly and Company (NYSE:LLY) Trading Down 3.2%Time to Sell? - MarketBeat
Fisher Asset Management Boosts Eli Lilly Stake - National Today
First Long Island Investors Boosts Eli Lilly Stake - National Today
Longview Advantage ETF Trims Stake in Eli Lilly and Co - National Today
Tech giants see a cure for cancer in AI. But Eli Lilly’s CEO finds it ‘not particularly good’ at solving biology or chemistry problems - AOL.com
Eli Lilly & Co. stock underperforms Monday when compared to competitors - MarketWatch
Eli Lilly and Co Stock Closed Down by 3.27% on Mar 2: Facts Behind the Movement - TradingKey
0.32%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):